Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2011-04-19 Regulatory Filings
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2011-04-19 English
Earnings Release 2011
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "Item 2.02 Results of Operations and Financial Condition" and references a press release announcing sales and earnings for the first quarter ended April 3, 2011. It also includes unaudited supplementary sales data and condensed consolidated statement of earnings. The document is short (2348 characters) and primarily serves as an announcement of quarterly financial results rather than a full detailed report. This matches the characteristics of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. Therefore, the correct classification is ER with high confidence.
2011-04-19 English
J&J AND MERCK ARBITRATION SETTLEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes an arbitration settlement between Johnson & Johnson and Merck, including amended distribution rights and the conclusion of an arbitration proceeding. It includes references to attached press releases but does not contain financial statements or detailed financial data itself. The document is not an annual or quarterly report, nor is it a transcript, proxy, or governance document. It is a regulatory announcement of a significant event, fitting the category of Regulatory Filings (RNS). The document length is under 5,000 characters and primarily serves as a notification rather than a full report.
2011-04-15 English
EIGHT-K DPA FCPA
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing with the SEC, which is used for current reports to announce major events. The content describes a settlement related to Foreign Corrupt Practices Act investigations, including payment of fines and disgorgement. It references an attached press release as Exhibit 99.1. The document is short (2422 characters) and primarily announces an event rather than providing detailed financial data or a full report. This fits the category of Regulatory Filings (RNS), which is a fallback for miscellaneous filings that do not fit other specific categories and includes current event disclosures like this one.
2011-04-08 English
PRIMARY DOCUMENT
Director's Dealing
2011-04-04 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2011-03-23 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.